Source: Eur Respir J, 57 (6) 1900716; 10.1183/13993003.00716-2019



Rating:

Share or cite this content

Citations should be made in the following way:
Matthias Hagner, Melanie Albrecht, Matteo Guerra, Peter Braubach, Olga Halle, Zhe Zhou-Suckow, Simone Butz, Danny Jonigk, Gesine Hansen, Carsten Schultz, Anna-Maria Dittrich, Marcus A. Mall. IL-17A from innate and adaptive lymphocytes contributes to inflammation and damage in cystic fibrosis lung disease. Eur Respir J, 57 (6) 1900716; 10.1183/13993003.00716-2019

Member's Comments

No comment yet.

Related content which might interest you: The innate immune function of airway epithelial cells in inflammatory lung disease Source: Eur Respir J 2015; 45: 1150-1162 Year: 2015 Lack of an exaggerated inflammatory response on virus infection in cystic fibrosis Source: Eur Respir J 2012; 39: 297-304 Year: 2012 Disturbance of pro-inflammatory cytokine production in patients with cystic fibrosis lung disease Source: Eur Respir J 2005; 26: Suppl. 49, 404s Year: 2005 Treg depletion reduces bleomycin-induced pulmonary fibrosis by inducing Th17 and other CD4+T cell subset responses in lung Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Inflammatory response to infectious pulmonary injury Source: Eur Respir J 2003; 22: 10S-14S Year: 2003 Soluble ADAM33 augments the pulmonary innate immune response promoting susceptibility to allergic airway inflammation Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases Year: 2018 The role of chemokines and cytokines in lung fibrosis Source: Eur Respir Rev 2008; 17: 151-156 Year: 2008 Inflammatory cytokines in airway secretions from patients with cystic fibrosis contribute to airway epithelial cell damage Source: Eur Respir J 2004; 24: Suppl. 48, 384s Year: 2004 The PD-1 immune checkpoint promotes lung damage in murine models of COPD-like inflammation Source: International Congress 2019 – Injury and repair: less is more Year: 2019 Mechanisms and markers of airway inflammation in cystic fibrosis Source: Eur Respir J 2002; 19: 333-340 Year: 2002 M2 polarized alveolar macrophages in pulmonary fibrosis Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms Year: 2005 Role of IL23 in the development of fibrotic interstitial lung disease Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019 Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases Source: Eur Respir J 2008; 32: 1068-1081 Year: 2008 Treg alterations lead to systemic and local immune deregulation in idiopathic pulmonary fibrosis and collagen vascular disease-associated interstitial pneumonia Source: Annual Congress 2007 - Cell biology of asthma and COPD Year: 2007 Th2 immune response and respiratory bronchiolitis-associated interstitial lung disease in p66Shc KO smoking mice Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008 Impaired lung function is associated with systemic inflammation and macrophage activation Source: Eur Respir J 2015; 45: 557-559 Year: 2015 The role of monocyte inflammation and oxidant stress in the etiopathogenesis of cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 485s Year: 2006 Diffuse parenchymal lung inflammation response in patients with inflammatory bowel disease Source: Eur Respir J 2005; 26: Suppl. 49, 540s Year: 2005 Eosinophils as potential mediators of autoimmunity in eosinophilic lung disease Source: Eur Respir Monogr 2022; 95: 219-237 Year: 2022